SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-20-000050
Filing Date
2020-11-09
Accepted
2020-11-09 16:48:45
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20200930x10q.htm   iXBRL 10-Q 2909572
2 EX-31.1 plse-20200930xex31_1.htm EX-31.1 23552
3 EX-31.2 plse-20200930xex31_2.htm EX-31.2 23728
4 EX-32.1 plse-20200930xex32_1.htm EX-32.1 21321
  Complete submission text file 0001625101-20-000050.txt   8208607

Data Files

Seq Description Document Type Size
5 EX-101.SCH plse-20200930.xsd EX-101.SCH 35838
6 EX-101.CAL plse-20200930_cal.xml EX-101.CAL 50865
7 EX-101.DEF plse-20200930_def.xml EX-101.DEF 126984
8 EX-101.LAB plse-20200930_lab.xml EX-101.LAB 317475
9 EX-101.PRE plse-20200930_pre.xml EX-101.PRE 282595
10 EXTRACTED XBRL INSTANCE DOCUMENT plse-20200930x10q_htm.xml XML 1485783
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 201298388
SIC: 3841 Surgical & Medical Instruments & Apparatus